Capricor Therapeutics Inc. (CAPR) has offered to sell 3 million shares of its common stock at a price of $3.20 each. The proceeds to Capricor from the offerings are expected to be approximately $8.7 million. The company had cash of about $11.4 million at June 30, 2016.
from RTT - Biotech http://ift.tt/2cobhHH
via IFTTT
No comments:
Post a Comment